Cogentix Medical (CGNT) Tops Q4 EPS by 13c, Offers Guidance

Cogentix Medical (NASDAQ: CGNT) reported Q4 EPS of $0.36, $0.13 better than the analyst estimate of $0.23. Revenue for the quarter came in at $124 million versus the consensus estimate of $123.46 million.

GUIDANCE:

Cogentix Medical sees Q1 2021 EPS of $0.15, versus the consensus of $0.12. Cogentix Medical sees Q1 2021 revenue of $113-115 million, versus the consensus of $112.1 million.

Cogentix Medical sees FY2021 EPS of $0.80, versus the consensus of $0.88. Cogentix Medical sees FY2021 revenue of $490 million, versus the consensus of $486.6 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Stitch Fix (SFIX) Tops Q3 EPS by 4c, Offers Guidance
• Academy Sports and Outdoor (ASO) Misses Q1 EPS by 1c ; Offers Guidance